- Home
- RCKT vs CNMD Comparison
RCKT vs CNMD Comparison
Compare RCKT & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- CNMD
- Stock Information
- Founded
- RCKT 1999
- CNMD 1970
- Country
- RCKT United States
- CNMD United States
- Employees
- RCKT N/A
- CNMD N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RCKT Health Care
- CNMD Health Care
- Exchange
- RCKT Nasdaq
- CNMD Nasdaq
- Market Cap
- RCKT 264.0M
- CNMD 1.7B
- IPO Year
- RCKT N/A
- CNMD 1987
- Fundamental
- Price
- RCKT $2.99
- CNMD $51.64
- Analyst Decision
- RCKT Buy
- CNMD Hold
- Analyst Count
- RCKT 13
- CNMD 5
- Target Price
- RCKT $18.50
- CNMD $62.20
- AVG Volume (30 Days)
- RCKT 3.8M
- CNMD 423.1K
- Earning Date
- RCKT 08-04-2025
- CNMD 07-30-2025
- Dividend Yield
- RCKT N/A
- CNMD 1.49%
- EPS Growth
- RCKT N/A
- CNMD 46.38
- EPS
- RCKT N/A
- CNMD 3.81
- Revenue
- RCKT N/A
- CNMD $1,315,998,000.00
- Revenue This Year
- RCKT N/A
- CNMD $6.27
- Revenue Next Year
- RCKT N/A
- CNMD $5.62
- P/E Ratio
- RCKT N/A
- CNMD $14.06
- Revenue Growth
- RCKT N/A
- CNMD 4.32
- 52 Week Low
- RCKT $2.19
- CNMD $46.00
- 52 Week High
- RCKT $26.98
- CNMD $78.19
- Technical
- Relative Strength Index (RSI)
- RCKT 45.55
- CNMD 41.34
- Support Level
- RCKT $2.76
- CNMD $51.20
- Resistance Level
- RCKT $3.24
- CNMD $54.81
- Average True Range (ATR)
- RCKT 0.19
- CNMD 1.83
- MACD
- RCKT 0.17
- CNMD 0.07
- Stochastic Oscillator
- RCKT 74.85
- CNMD 22.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.